Human Recombinant IGF-II (from E. coli)

Supplier: VWR International

VWR100-14AF-10UG VWR100-14AF-1MG VWR100-14AF-500UG VWR100-14AF-50UG VWR100-14AF-100UG
77750-474EA 163.58 CAD
77750-474 77750-476 77750-478 77750-480 77750-472
Human Recombinant IGF-II (from E. coli)
Proteins and Peptides

Insulin-like growth factor II (IGF-II) is an important fetal growth hormone made by theca cells during gestation. IGF-II engages the IGF-I receptor (IGF1R) to mediate embryonic growth. IGF-II also binds the sink IGF-II receptor (IGF2R) leading to IGF-II degradation.


  • High quality
  • Low endotoxin
  • Affordable


Caution: For research use only.

New Product

Order Now

SPECIFICATIONS

Protein/peptide name IGF-II
Environmentally Preferable
Protein synonyms Somatomedin A
Protein/peptide type Recombinant
Protein Function Cytokine
Species Human
Source E. coli
Conjugation Unconjugated
Gene ID P01344
Sequence AYRPSETLCG GELVDTLQFV CGDRGFYFSR PASRVSRRSR GIVEECCFRS CDLALLETYC ATPAKSE
Protease-free N
Animal-free Y
Nuclease-free N
Carrier-free Y
Endotoxin-free N
Endotoxin level Low
Endotoxin content Endotoxin LAL (EU/µg) ≤0.1
Biological activity Bioactivity assay: rh IGF-II activity is tested in human breast cancer cell line MCF-7; ED50 ≤6 ng/ml; Bioactivity ≥1.7×10⁵ units/mg
Purity ≥95%
Grade RUO
Formulation 0.1% Trifluoroacetic Acid (TFA)
Molecular weight 7.5 kDa
Reconstitution instructions Sterile water at 0.1 mg/ml
Storage conditions –20 °C
Shipping temperature RT
Tested applications Bioassay

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR